Member Info for passiton

can I pay you 25p a share not too lol

London stock exchange showed trades into close at 8.5 and 8.8 and closed in auction at 8p
then going into daily market generated PME's
No indication of end of PME price, find out when it resets just prior to open in the morning
with all the delayed trades thrown in, thinking a possible gap up to start the day after that
who knows which way the volatility will take it. Good luck to all in the morning. Goodnight

Just look at the transformations on the many so far that at the end of the day only have a test kit
which will never stop you getting the virus and will not help when your dying in ICU 50/50 chance

HEMO has the potential to have a beyond vaccine direct injection of antibodies for infected patients
better than a vaccine as they are less effective with age and compromised immune systems covid's
favourite target group
This could also be used as a super vaccine already containing high concentrate antibodies that may
or may not have been generated by a normal vaccine to a level to supress and kill a future invader.
So the worldwide potential is immense IF they crack it
Then apply the same model as they plan against other diseases known and unknown virus X and
the long term game changing potential to the field of virology is clear to see
They have already had success with trials of their cancer model for AAL and AML Lukemia which in
itself could multibag Hemo and several other projects already ongoing with Global Pharms under
NDA' s others with Johnson & Johnson's Janssen
Now its all eyes on news and results across Hemo's project portfolio not just the covid potential
short, medium and long term gains to be made on this little Main Market Gem. GLA

me too OZ but have already settled in on this one for a longer hold and those is the isa going
nowhere until much higher than 20p in a year or 2 (£'s target subject to any dilution etc)

Chinese whisper misheard, Donald was referring to it being sore when he sat down due
to hemo………...

Directly after the Germans who have had a better handle on things that most, disagreed with
the Swiss decision their top science advisor stating its too early and not enough evidence
one way or the other yet to make such a decision

Suggest they read a few further back, this is Main Market and not a flavour of the month one trick pony
World Class team , World Class innovative patented methodologies and now a potential game changer
for current and future unknown diseases

AND Cracking summations and post's earlier et al especially JAdam

MAIN MARKET listed not an aim fly by night, multiple projects prior to the covid news, including a successfully
tested AAL/AML Lukemia treatment (that will be worth a few bob down the line into production)
Multiple GLOBAL PHARM in tow on various projects some under NDA but Janssen, Johnson & Johnson named

The only question is which of G.P's with DEEP POCKETS will push for the Covid antibody treatment (cure in
my thinking as it eradicates the virus) and World Wide production up scaling will not be a problem to a G.P
and the model is not just for this crisis , as stated it is also for future unknown VIRUS X when another appears

This is a LONG term play way beyond Covid-19 many will profit in the short term but if not taken out by one
of the big partners, those that tuck some low sp away for the longer journey will make a mint.

Many II and ASM's have a minimum £50m market capital as an investment criteria, that's now in play
now the fun could really begin, covid antibody treatment potential on top of already successful cancer
treatment and other projects, HEMO should have many eyes on it

That's the big question HRGG

its the RNA we are wishing for, like sng in the uk as both have inhaler direct to lungs drugs and now
in addition tils just announced a combo to also attack the virus antiviral + il6 (lung treatment)

Spot on Glenn if they crack this is a monster and already had Cancer treatment success and others
waiting in the wings put this straight in the isa sub/2p I see a 100+bagger long term so see where
it is in a year or 2 if not taken out by one of its Global Pharm partners

Read the RNA looking to create an antibody treatment, that's like injecting a live working super vaccine
as its already got the antibodies not reliant on the body creating them and can use on the infected
to treat (cure) kill the virus, could also double up as a prevention vaccine HUGE

Well said Asher
they all go when they are ready, no matter how much we shareholder wish otherwise
at $3 both last months placing and the new available $20M if all converted at same
around 10M Nasdaq shares in total = 50M AIM they churned around 70M last week so
since placing in March the volume on both NQ/AIM we must be well into the churn even
if converting the lot

Why on earth would they need to issue a speeding ticket , just released 2 big rna seller cleared
and not even mentioned things like the other projects include a successful treatment for
cancer lukemia in collaboration with at least 3 Global Pharms on various other diseases the
only question I have is WHICH of those pharms or other will come out of the shadow's to take
the new antibody development up and produce on a worldwide scale ?????

Let me see potential antibody cure for this and future diseases v tests that will never stop you getting ill
or treat/cure you just give you the bad news you've got it you may or may not develop symptoms that
send you to icu for a 50/50 lottery

Now I wonder why we are flying …………...

I was beating the drum on twitter Hemo last week at the time 8-9 M market cap looking to a possible treatment/cure
and all the lung treatments and test kits mostly 50-255M was out of whack in the grand scheme of things

The demand for tests will wane over time, the drugs developed for this virus and the advances made
will be required for the long term for this and future similar viruses original H1N1 Spanish flu hundred
years ago other less virulent since apart from a couple sar2 2009 etc, so little doubt this nightmare to
occur again in the future but after this Governments etc will not want to be caught out so badly next
time so future funding for virology pharm's a dead cert. Same with PPE stockpiling IN CASE

the lung anti-inflammatory has already been in trails for other similar lung problems copd etc
just like sng drug had so no reason why that in itself with inhaler application could not move
rapidly, the combo may have some additional hoops due to the added antiviral element

Missing the point Sam if fast tracked like sng it would be getting tested live in patients currently in hospital
FDA last month announced the rule book is out of the window for anything that can help in the fight with
covid USA is desperate for something anything that will cut the death rate,, so if that announced like sng
it would be within 1-2 weeks of effectively going live trials at which point we could go off on one like they
did.

If they crack the production of antibodies outside of the body, can be used both as an injected treatment (cure)
and as a superior vaccine, already working on application as oppose to may or may not be created in the body
from vaccine depending on individual immune system response and in this case that is critical as vaccines are
not as effective with age and the compromised immune (other illness degraded) which unfortunately is the
most high risk with Covid-19
IF they do succeed then yes NCYT % rise and beyond is certainly possible and we have not even mentioned
the multiple other projects already in play with several Global Pharms, this is a stock for short and longterm
future beyond covid